As shown in Figure 2E and Table S5, DMP-A was mainly presented a CD4+ immune regulator and stromal activation phenotype, associated with many related pathways, such as the cell cycle, DNA replication, Toll-like receptor, and Nod-like receptor signaling pathways in cancer. The gene discussed is CD4; the disease is cancer.